Participants' Experience of Psychedelic Integration Groups and Processes: A Qualitative Thematic Analysis.

ABSTRACT:

Background

Psychedelics such as psilocybin, lysergic acid diethylamide, and 3,4-methylenedioxymethamphetamine are increasingly recognized for their potential therapeutic benefits in treating complex and chronic mental health conditions. Growing public interest in psychedelics may drive increased consumption outside of medically supervised clinical trials. Correspondingly, legality issues and potential risks of unregulated use underscore the need for structured aftercare support, including psychedelic integration groups, to reduce harm potential.

Methods

This study utilized a cross-sectional, observational, online, anonymous survey with 65 participants who used psychedelics and attended psychedelic integration groups. Participants provided qualitative data on their experience

SUBMITTER: Modlin NL 

PROVIDER: S-EPMC12054613 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature